Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Peretz Lavie a Sleep Laboratory, Bruce Rappaport Faculty of
Medicine, Israel Institute of Technology, Haifa, Israel, b Division of Respiratory
Medicine, St Michael's Hospital, University of Toronto, Ontario,
Canada
Correspondence to: P Lavie plavie{at}techunix.technion.ac.il
| |
Abstract |
|---|
|
|
|---|
Objective:
To assess whether sleep apnoea syndrome is an independent risk factor for hypertension.
The strong association between obstructive sleep apnoea syndrome
and hypertension has attracted considerable attention in recent
years.1-6 Despite the accumulated evidence suggesting a
causal relation between these two conditions, doubts have been raised
about how much of this association is contributed by confounding variables, most notably obesity, age, and male sex. This argument diminished the importance of the syndrome as a major public health problem.7 Differentiating the contribution of confounding
factors from that of the repeated apnoeic events and hypoxaemia
requires large populations. In an unselected population of state
employees, sleep related breathing disorders were a risk factor for
hypertension, which was independent of age, body mass index, and
sex.6 However, because the population was a sample of the
general population rather than of patients with suspected sleep
disorders, less than 4% of that population had moderate or severe
sleep apnoea.6
No large scale investigations have examined the relation between
blood pressure, severity of apnoea, and various confounding factors in
patients attending sleep clinics. These patients generally present with
more severe forms of sleep related breathing disorders and more
confounding variables than the general population, and therefore may be
expected to show a different relation between apnoeic events and blood
pressure. We investigated these relations in a large population of
patients with sleep disorders attending a clinic.
Participants
Protocol
Design:
Population study.
Setting:
Sleep clinic in Toronto.
Participants:
2677 adults, aged 20-85 years, referred
to the sleep clinic with suspected sleep apnoea syndrome.
Outcome measures:
Medical history, demographic data,
morning and evening blood pressure, and whole night polysomnography.
Results:
Blood pressure and number of patients with hypertension increased linearly with severity of sleep apnoea, as shown
by the apnoea-hypopnoea index. Multiple regression analysis of blood
pressure levels of all patients not taking antihypertensives showed
that apnoea was a significant predictor of both systolic and diastolic
blood pressure after adjustment for age, body mass index, and sex.
Multiple logistic regression showed that each additional apnoeic event
per hour of sleep increased the odds of hypertension by about 1%,
whereas each 10% decrease in nocturnal oxygen saturation increased the
odds by 13%.
Conclusion:
Sleep apnoea syndrome is profoundly
associated with hypertension independent of all relevant risk factors.
![]()
Introduction
Top
Abstract
Introduction
Methods
Results
Discussion
References
![]()
Methods
Top
Abstract
Introduction
Methods
Results
Discussion
References
We examined prospectively 2677 adults (aged 20-85 years) referred
to the St Michael's Hospital sleep clinic with suspected sleep apnoea.
All were both non-selected and consecutively referred for diagnostic
sleep recordings over a 10 year period.
Nocturnal polysomnography was performed in hospital. This included monitoring of both respiration, with inductance plethysmography and oronasal temperature as substitute measurements of
respiratory effort and flow, and oxygen saturation. From these measures
we obtained the apnoea-hypopnoea index (total number of apnoeic events
plus hypopnoeic events divided by hours of sleep) and the lowest and
mean nocturnal oxygen saturation; we also recorded the percentage of
time spent asleep with oxygen saturation below 90%. Apnoea was defined
as a cessation in airflow of at least 10 seconds, and hypopnoea was
defined as a decrease in the amplitude of the respiratory signal of at
least 50% for a minimum of 10 seconds followed by either a decrease in
oxygen saturation of 4% or signs of physiological arousal.
We measured the patients'
height and weight and neck, hip, and waist circumference, and we
calculated their body mass index and waist to hip ratio.
Hypertension
Hypertension was defined as taking antihypertensives without
regard to the actual measurement of blood pressure, or having a
systolic blood pressure reading greater than 140 mm Hg or a diastolic
blood pressure reading greater than 90 mm Hg. The same definition was
used in a study of hypertension in sleep apnoea based on a random
sample of the population.6
Statistical analysis
We analysed the association between sleep apnoea and blood
pressure with univariate analysis, without any adjustment for
confounding variables. Linear trends were verified using the
Cochran-Armitage trend test8 for linearity for categorical data, and regression lines for parametric data. We used multiple linear
regression to identify the variables that made an important contribution to the variability of blood pressure and to adjust for
confounding variables with analysis of covariance. Finally, we used
multiple logistic regression modelling to determine the odds ratios of
having hypertension associated with an increase in the apnoea-hypopnoea
index and a decrease in oxygen saturation. Statistical analysis was
performed using SAS software.
| |
Results |
|---|
|
|
|---|
Univariate analysis
Table 1 summarises the characteristics of the patient
population of 1949 men and 728 women. Our patients were obese, middle
aged males with mild to moderate sleep apnoea, and there was wide
scatter in all variables.
|
|
|
We performed
multiple linear regression in 1865 patients not taking
antihypertensives (table 3). This showed that the apnoea-hypopnoea
index was significantly related to diastolic and systolic blood
pressure after adjustment for age and sex. Age and sex were significant
covariates, but there was no interaction between the apnoea-hypopnoea
index and age or sex. Smoking was only borderline statistically
significant for the diastolic blood pressure, and therefore it was not
included in further analysis. Stepwise linear regression, with the
apnoea-hypopnoea index, age, and sex forced in the model, indicated
that neck circumference (over body mass index, waist or hip
circumference, and waist to hip ratio) was the most influential body
habitus variable. When neck circumference was added to age and sex, the
apnoea-hypopnoea index was still significantly related to diastolic and
systolic blood pressures (adjusted R2 21.9%
and 19.6% respectively). No interaction occurred between neck
circumference and the apnoea-hypopnoea index. Under the conditions of
the model, the
coefficient for the apnoea-hypopnoea index indicates
an increase of 0.10 and 0.04 mm Hg in systolic and diastolic blood
pressures respectively for each additional apnoeic event per hour of
sleep. The model predicts, for example, that the mean (SD) morning
blood pressure readings will be 6 (1.2) mm Hg (systolic) and 4.7 (1.0)
mm Hg (diastolic) higher for severe sleep related breathing disorders
(apnoea-hypopnoea index 60) versus no sleep related breathing
disorders. The same results were found when the analysis was repeated
with the lowest nocturnal oxygen saturation.
Multiple logistic regression
To evaluate the effect of
the apnoea-hypopnoea index, we performed a multiple logistic regression model of sleep related breathing disorders and hypertension with terms
for the apnoea-hypopnoea index, sex, age, body mass index, and an
interaction for body mass index and apnoea-hypopnoea index. This
indicated that an increase in 10 apnoeic events per hour of sleep
increased the risk of having hypertension by about 11.0% (
coefficient 0.011, table 4 and fig 1). A similar analysis replacing the
apnoea-hypopnoea index with oxygen saturation nadir showed that each
10% decrease in saturation nadir increased the risk of having
hypertension by about 13% (0.013; table 5 and fig 2). Using percentage
of time spent asleep below 90% oxygen saturation instead of nadir did
not improve upon these results.
| |
Discussion |
|---|
|
|
|---|
We investigated the relation between the severity of sleep apnoea syndrome and hypertension in 2677 people attending a sleep clinic. Overall, 40% of our population were defined as hypertensive based on either medical history or blood pressure measurements taken immediately after sleep. Our results showed that sleep apnoea significantly contributed to hypertension independent of all relevant confounding variables. Each apnoeic event per hour of sleep added about 1% to the risk of having hypertension. To prove that sleep apnoea has an independent effect on blood pressure we used techniques for adjustment of case mix based on multivariate statistical models to account for several variables that are strong confounders. Since multiple regression models cannot completely remove confounding effects, we confirmed our results by matching patients with sleep apnoea (apnoea-hypopnoea index greater than 10; no use of antihypertensives), for age (within SD 5 years) and body mass index (within SD 2 kg/m2) with controls (apnoea-hypopnoea index 10 or less). The 674 patients with sleep apnoea we successfully matched (data not shown) had significantly higher blood pressure measurements than their matched controls (122.4 (SD 15.7) versus 118.7 (15.5) mm Hg, t=4.67, paired t test P<0.0001; 73.7 (10.2) versus 70.9 (9.9) mm Hg, t=5.20, P<0.0001).
|
|
|
|
Our 1% estimate of risk for hypertension for each event per hour of sleep is lower than the 4% previously reported.6 This may be because our reference group comprised a large number of heavy snorers who were suspected of having sleep apnoea but who were found to have an apnoea-hypopnoea index lower than 10. Snoring was previously reported to be associated with increased levels of blood pressure.9
Active approach in diagnosis
Our findings, together with previous
reports,
5 6
show that sleep apnoea constitutes an
independent risk factor for hypertension. Multivariate analysis of
mortality data in patients with sleep apnoea showed that hypertension
was a significant independent predictor of cardiopulmonary deaths in
these patients.10 These findings have clinical
implications concerning diagnosis and treatment of sleep apnoea.
Currently, most patients are referred for diagnosis only when symptoms
are severe enough to affect their quality of life or to attract the
attention of family members. Snorers, even with obvious daytime
sleepiness, were reported to be passive in seeking medical help for
their symptoms.11 The association of sleep apnoea with
hypertension warrants a more active approach in the diagnosis of sleep
apnoea.
|
What is already known on this topic
Previous studies have suggested that sleep apnoea syndrome is associated with hypertension, but until now evidence from a large population attending a sleep clinic in which confounders were controlled for has been lacking What this paper addsBased on either medical history or actual blood pressure measurements there is an association between sleep apnoea and hypertension, which is independent of the most important confounders Sleep apnoea syndrome should be taken into account in the differential diagnosis of essential hypertension |
| |
Acknowledgments |
|---|
We thank Ms Gay Natanzon for editing and checking the manuscript.
Contributors: PL designed the data analysis and wrote the paper. VH was responsible for data collection and organising the database and participated in writing the paper. PH performed the statistical analysis.
| |
Footnotes |
|---|
Funding: Technion Sleep Disorders Center (SDC).
Competing interests: None declared.
| |
References |
|---|
|
|
|---|
| 1. | Hoffstein V, Chan CK, Slutsky AS. Sleep apnea and systemic hypertension: a causal association review. Am J Med 1991; 91: 190-196[CrossRef][Medline]. |
| 2. | Fletcher EC. The relationship between systemic hypertension and obstructive sleep apnea: facts and theories. Am J Med 1995; 98: 118-128[CrossRef][Medline]. |
| 3. |
Millman RP, Redline S, Carlisle CC, Assaf AR, Levinson PD.
Daytime hypertension in obstructive sleep apnea. Prevalence and contributing risk factors.
Chest
1991;
99:
861-886 |
| 4. | Silverberg DR, Oksenberg A, Radwan H, Iaina A. Sleep related breathing disorders are common distributing factors to the production of essential hypertension but are neglected, underdiagnosed and undertreated. Am J Hypertens 1997; 10: 1319-1325[Medline]. |
| 5. |
Hla KM, Young TB, Bidwell T, Palta M, Skatrud JB, Dempsey J.
Sleep apnea and hypertension. A population-based study.
Ann Intern Med
1994;
120:
382-388 |
| 6. | Young T, Peppard P, Palta M, Hla KM, Finn L, Morgan B, Skatrud J. Population-based study of sleep-disordered breathing as a risk factor for hypertension. Arch Intern Med 1997; 157: 1746-1752[Abstract]. |
| 7. |
Wright J, Johns R, Watt I, Melville A, Sheldon T.
Health effects of obstructive sleep apnoea and the effectiveness of continuous positive airways pressure: a systematic review of the research evidence.
BMJ
1997;
314:
851-860 |
| 8. | Fleiss L. Statistical methods for rates and proportions 2nd ed. New York: Wiley, 1981. |
| 9. | Young T, Finn L, Hla KM, Morgan B, Palta M. Snoring as part of a dose-response relationship between sleep-disordered breathing and blood pressure. Sleep 1996; 19: 202-25S. |
| 10. |
Lavie P, Herer P, Peled R, Berger I, Yoffe N, Zomer J, et al.
Mortality in sleep apnea patients a multivariate analysis of risk factors.
Sleep
1995;
18:
149-157[Medline].
|
| 11. | Martikainen K, Pertinen M, Urponen H, Vuori I, Laippala P, Hasa J. Natural evolution of snoring: a 5-year follow-up study. Acta Neurol Scand 1994; 90: 437-442[Medline]. |
(Accepted 2 December 1999)
Read all Rapid Responses
What can you learn from this BMJ paper? Read Leanne Tite's Paper+